Healthcare provider profile · identity verified

Scott A Smiley, MD

Internal Medicine · EMPORIA, KS · NPI 1417984618

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	476	113
Levothyroxine Sodium	Levothyroxine Sodium	461	118
Lisinopril	Lisinopril	358	84
Losartan Potassium	Losartan Potassium	286	74
Amlodipine Besylate	Amlodipine Besylate	280	77
Omeprazole	Omeprazole	278	62
Warfarin Sodium	Warfarin Sodium	236	33
Furosemide	Furosemide	228	46
Pantoprazole Sodium	Pantoprazole Sodium	224	62
Gabapentin	Gabapentin	218	45
Eliquis	Apixaban	207	27
Potassium Chloride	Potassium Chloride	201	35
Metformin Hcl	Metformin Hcl	173	47
Rosuvastatin Calcium	Rosuvastatin Calcium	171	43
Metoprolol Succinate	Metoprolol Succinate	156	38
Tamsulosin Hcl	Tamsulosin Hcl	147	37
Hydrochlorothiazide	Hydrochlorothiazide	146	42
Simvastatin	Simvastatin	146	38
Carvedilol	Carvedilol	145	34
Tramadol Hcl	Tramadol Hcl	132	32
Escitalopram Oxalate	Escitalopram Oxalate	131	25
Montelukast Sodium	Montelukast Sodium	130	29
Allopurinol	Allopurinol	124	26
Spironolactone	Spironolactone	110	31
Metoprolol Tartrate	Metoprolol Tartrate	106	30
Albuterol Sulfate Hfa	Albuterol Sulfate	102	34
Clopidogrel	Clopidogrel Bisulfate	93	24
Prednisone	Prednisone	92	65
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	79	34
Meloxicam	Meloxicam	78	32
Tizanidine Hcl	Tizanidine Hcl	77	21
Buspirone Hcl	Buspirone Hcl	76	15
Pravastatin Sodium	Pravastatin Sodium	75	19
Ozempic	Semaglutide	73	13
Pioglitazone Hcl	Pioglitazone Hcl	67	14
Xarelto	Rivaroxaban	66	suppressed
Duloxetine Hcl	Duloxetine Hcl	65	16
Jardiance	Empagliflozin	64	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	62	46
Glimepiride	Glimepiride	62	19
Baclofen	Baclofen	61	11
Diclofenac Sodium	Diclofenac Sodium	59	17
Synthroid	Levothyroxine Sodium	57	suppressed
Ezetimibe	Ezetimibe	56	12
Novolog Flexpen	Insulin Aspart	53	12
Sertraline Hcl	Sertraline Hcl	53	13
Tresiba Flextouch U-100	Insulin Degludec	53	16
Famotidine	Famotidine	48	suppressed
Trulicity	Dulaglutide	48	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	47	suppressed
Atenolol	Atenolol	46	15
Azithromycin	Azithromycin	45	38
Cephalexin	Cephalexin	45	32
Fluticasone Propionate	Fluticasone Propionate	44	16
Pregabalin	Pregabalin	44	suppressed
Metformin Hcl Er	Metformin Hcl	43	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Trazodone Hcl	Trazodone Hcl	40	suppressed
Finasteride	Finasteride	39	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Bumetanide	Bumetanide	37	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	36	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	12
Triamcinolone Acetonide	Triamcinolone Acetonide	36	27
Hydroxyzine Hcl	Hydroxyzine Hcl	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Propranolol Hcl	Propranolol Hcl	34	suppressed
Bupropion Hcl Sr	Bupropion Hcl	33	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	33	suppressed
Sotalol	Sotalol Hcl	33	suppressed
Clonazepam	Clonazepam	32	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	32	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	31	suppressed
Entresto	Sacubitril/Valsartan	31	suppressed
Telmisartan	Telmisartan	30	suppressed
Mirtazapine	Mirtazapine	29	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Alprazolam	Alprazolam	27	suppressed
Celecoxib	Celecoxib	27	suppressed
Morphine Sulfate Er	Morphine Sulfate	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Diazepam	Diazepam	25	suppressed
Primidone	Primidone	25	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Torsemide	Torsemide	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Rybelsus	Semaglutide	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	18
Bupropion Xl	Bupropion Hcl	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Flecainide Acetate	Flecainide Acetate	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Amoxicillin	Amoxicillin	17	12
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Glipizide	Glipizide	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Nystatin	Nystatin	16	11
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	14	suppressed
Levofloxacin	Levofloxacin	14	11
Olanzapine	Olanzapine	14	suppressed
Cilostazol	Cilostazol	13	suppressed
Digoxin	Digoxin	13	suppressed
Dilt-Xr	Diltiazem Hcl	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Temazepam	Temazepam	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Naproxen	Naproxen	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Cefuroxime	Cefuroxime Axetil	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error